MedPath
NMPA Approval

Lornoxicam for Injection

国药准字H20254046

April 30, 2025

Drug Information

注射用氯诺昔康

注射剂

8mg(每瓶实装8.6mg)

化学药品

April 30, 2025

Company Information

Applicant Company

成都高新区科园南路88号2栋1层107号

Manufacturing Company

成都海峡两岸科技产业开发园柳台大道B段

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氯诺昔康 - NMPA 批准文号 | MedPath